TROW
62
6
CHD
35
-5
WYNN
48
-2
PNW
55
2
LUV
70
2
AMAT
54
2
MO
54
3
ITW
40
3
AVB
39
5
WMT
55
-4
SLG
37
6
CHRW
79
-3
C
84
2
V
54
2
ROP
42
4
AMG
82
5
TRIP
52
3
TJX
55
2
APD
50
5
PX
53
3
TROW
62
6
CHD
35
-5
WYNN
48
-2
PNW
55
2
LUV
70
2
AMAT
54
2
MO
54
3
ITW
40
3
AVB
39
5
WMT
55
-4
SLG
37
6
CHRW
79
-3
C
84
2
V
54
2
ROP
42
4
AMG
82
5
TRIP
52
3
TJX
55
2
APD
50
5
PX
53
3
Financhill
Back

Cytek Biosciences, Inc. 10K Form

Buy
65

CTKB
Cytek Biosciences, Inc.

Last Price:
$5.05
Seasonality Move:
13.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CTKB News And Ratings

See the #1 stock for the next 7 days that we like better than CTKB

CTKB Financial Statistics

Sales & Book Value

Annual Sales: $200.5M
Cash Flow: $-4.6M
Price / Cash Flow: 54.4
Annual Sales: $2.96
Price / Book: 1.72

Profitability

EPS (TTM): -0.10120
Net Income (TTM): $-12.8M
Gross Margin: $111.1M
Return on Equity: -3.34%
Return on Assets: -2.6%

Cytek Biosciences, Inc. Earnings Forecast

Key Cytek Biosciences, Inc. Financial Ratios

  • The Gross Profit Margin over the past 6 years for CTKB is 55.43%.
  • The Selling, General & Administrative Expenses for CTKB have been equal to 46.01% of Gross Profit Margin.
  • The Research & Development expenses have been 19.66% of Revenue.
  • The Net Earning history of CTKB is -3.00% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

Cytek Biosciences, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: CTKB
Website: cytekbio.com

Debt

Debt-to-Equity Ratio: 0.09
Current Ratio: 5.17
Quick Ratio: 4.23

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 158.33

CTKB Technical Analysis vs Fundamental Analysis

Buy
65
Cytek Biosciences, Inc. (CTKB) is a Buy

Is Cytek Biosciences, Inc. a Buy or a Sell?